Next Article in Journal
The Ribonuclease A Superfamily in Humans: Canonical RNases as the Buttress of Innate Immunity
Next Article in Special Issue
Direct LAMP Assay without Prior DNA Purification for Sex Determination of Papaya
Previous Article in Journal
1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione Induces G1 Cell Cycle Arrest and Autophagy in HeLa Cervical Cancer Cells
Previous Article in Special Issue
The Potential for Microalgae as Bioreactors to Produce Pharmaceuticals
Open AccessArticle

New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma

1
LKS Faculty of Medicine, School of Chinese Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China
2
Heimat Co., Ltd., Heimat Building, 1-21-3 Nihonbashi, Chuo-Ku, Tokyo 103-0027, Japan
3
Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangzhou 510055, China
*
Author to whom correspondence should be addressed.
Academic Editor: Chang Won Choi
Int. J. Mol. Sci. 2016, 17(8), 1277; https://doi.org/10.3390/ijms17081277
Received: 23 June 2016 / Revised: 20 July 2016 / Accepted: 28 July 2016 / Published: 5 August 2016
(This article belongs to the Special Issue Plant-Derived Pharmaceuticals by Molecular Farming 2016)
For the first time, we discovered a small proportion of aqueous fraction from Saw Palmetto apart from the fatty acid-rich fraction exhibited pharmacological activity. Therefore, this study aims to explore the anti-tumor potential of red pigmented aqueous fraction of Saw Palmetto, NYG on human hepatocellular carcinoma and its possible targets. Subcutaneous xenograft and orthotopic implantation models of HCC were used to evaluate the tumor inhibitory effect of NYG. Human hepatocellular carcinoma (HCC) cell lines and human umbilical vein endothelial cells (HUVEC) were used as in vitro model. The mRNA expression was conducted by qPCR. Protein expression was monitored by immunoblotting and immunohistochemistry. Cell migration and blood vessel formation were determined by chamber assay and tube formation assay, respectively. Significant tumor inhibition of NYG in dose-dependent manner was observed on subcutaneous xenograft and orthotopic HCC model. NYG has no direct action on cell viability or VEGF secretion of HCC cells. However, NYG reduced in vitro migration and vessel formation activities of HUVEC cells, as well as in vivo intratumoral neovascularization. NYG attenuated extracellular signal-regulated kinases (ERK) activation in endothelial cells, which may be associated with the suppression of migration and tube formation of HUVEC. NYG suppressed tumor expansion of HCC via inhibiting neovascularization, and may be potential adjuvant treatment for HCC. View Full-Text
Keywords: saw palmetto; NYG; hepatocellular carcinoma; HUVEC; angiogenesis saw palmetto; NYG; hepatocellular carcinoma; HUVEC; angiogenesis
Show Figures

Graphical abstract

MDPI and ACS Style

Tan, H.-Y.; Wang, N.; Takahashi, M.; Feng, Y.; Li, H.; Feng, Y. New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma. Int. J. Mol. Sci. 2016, 17, 1277. https://doi.org/10.3390/ijms17081277

AMA Style

Tan H-Y, Wang N, Takahashi M, Feng Y, Li H, Feng Y. New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2016; 17(8):1277. https://doi.org/10.3390/ijms17081277

Chicago/Turabian Style

Tan, Hor-Yue; Wang, Ning; Takahashi, Masao; Feng, Yigang; Li, Hongyun; Feng, Yibin. 2016. "New Natural Pigment Fraction Isolated from Saw Palmetto: Potential for Adjuvant Therapy of Hepatocellular Carcinoma" Int. J. Mol. Sci. 17, no. 8: 1277. https://doi.org/10.3390/ijms17081277

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop